Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:SM 16:1;O2/22:1)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteAnalysis Type
ST001205 AN002006 Peroxide antimalarial treatment of K13-mutant and -wildtype P. falciparum parasites Cultured cells Human Malaria Monash University LC-MS
ST001205 AN002006 Peroxide antimalarial treatment of K13-mutant and -wildtype P. falciparum parasites Cultured cells Plasmodium falciparum Malaria Monash University LC-MS
ST001033 AN001694 Determination of mode of action of anti-malalrial drugs using untargeted metabolomics Cultured cells Plasmodium falciparum Malaria Monash University LC-MS
ST000620 AN000952 Sphingolipid Analysis of hyper and normotensive DBA2J mice aqueous humor and trabecular meshwork Eye tissue Mouse Eye disease University of Miami MS(Dir. Inf.)
ST000613 AN000938 Human TM Sphingolipid Analysis (part II) Eye tissue Human Eye disease University of Miami MS(Dir. Inf.)
ST000612 AN000937 Sphingolipid Analysis of Human Aqueous Humor in Glaucomatous and Control eyes Eye tissue Human Eye disease University of Miami MS(Dir. Inf.)
ST000539 AN000818 Metabolomics-based elucidation of active metabolic pathways in erythrocytes and HSC-derived reticulocytes (part II) Cells Human Monash University LC-MS
ST000403 AN000642 Metabolomics-based elucidation of active metabolic pathways in erythrocytes and HSC-derived reticulocytes Cells Human Monash Institute of Pharmaceutical Sciences LC-MS
  logo